Atlas Trials

Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors

Clinical trial NCT02810600 · COMPLETED

Trial details

NCT number
NCT02810600
Sponsor
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Status
COMPLETED
Study type
OBSERVATIONAL
Neuroendocrine Tumors
Start date
2016-06-08
Primary completion
2020-01-01
Enrollment
2120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.